Mara R. Jonasson Email & Phone Number

Westlake Village, CA, US

Cambridge, MA, US

• Evaluate payer contract strategies to inform Pricing Committee recommendations, partner with National Account Directors to negotiate contract offers, draft/redline contract language, provide projections for Finance.
• TA: Rare Disease - Duchenne Muscular Dystrophy (DMD)
• Product Launch: Elevidys Gene Therapy
• Created financial model to assess GP (DRM, AMP, BP, Multiple BP) and GTN impacts of commercial contracting strategies for gene therapy. Scope of assessments includes value-based arrangements and warranty offerings.
• Developed rules-based approach for determining differential rebates in states where Medicaid managed care organizations have control over drug policy and/or carry the financial risk for the product.
• Led comprehensive review of GP reasonable assumptions documentation and drafted substantive updates to GP policies to account for Sarepta’s evolving business practices.

• Oversaw renovations of personal residence and planned micro-wedding in Scotland.

Burlington, Massachusetts, US

• Model impacts (ASP, GTN) of provider contract strategies and create recommendations for Pricing Committee. Draft/redline contract language, oversee execution of rebates, fee payments, and contract pricing/chargebacks..
• TA: Osteoarthritis
• Led successful implementation of commercial off-invoice discount pricing with Trade, Commercial Operations, Finance, 3PLs, and specialty distributors.

San Mateo, California, US

• Accountable for designing government pricing system enhancements for GP, DRM, and FSS modules. Collaborate with Top 25 biopharma manufacturers to implement flexible solutions that support compliance and industry.
• Utilized deep domain expertise to devise new discount reallocation functionality that did not require revision following significant mid-project requirement changes by two Top 5 biopharma companies.

Toronto, ON, CA

• Author GP policy, methodology, and reasonable assumptions documents. Conduct compliance assessments and conference presentations. Manage engagements, furnish client deliverables, direct project staff.
• Assisted biotech and pharmaceutical companies with remediation of Corporate Integrity Agreements.

Foster City, CA, US

• Analyze impact of business decisions and regulatory changes on Gilead’s pricing policies. Manage GP team, ensure government pricing and contracting compliance, oversee class of trade assignments, review the accuracy of.
• TAs: HIV/AIDS, Liver Disease, Hematology/Oncology, Cardiovascular, Inflammation/Respiratory
• Product Launches: Descovy®, Genvoya®, Odefsey®
• Partnered with Legal to interpret and implement the provisions of the Affordable Care Act (ACA).
• Assured business continuity by training two or more resources for each GP task.

Thousand Oaks, CA, US

• Assess impact of business decisions and regulatory changes on Amgen’s pricing policies and GTN. Manage staff, perform robust data validations, verify system-generated government prices through objective calculation.
• TAs: Oncology, Bone Health, Nephrology, Inflammation
• Product Launches: Vectibix®, Nplate®, Prolia®, XGEVA®
• Partnered with Legal to interpret and implement the provisions of the Deficit Reduction Act (DRA).
• Outlined discount reallocation requirements and created results verification models.
• Developed Risks and Control Matrix to mitigate risks to government price reporting. Led the creation of a GP sub-certification process to ensure execution of related controls.

Master Of Business Administration (Mba)

Certificate, Global Enterprise Management

Bachelor Of Science (Bs), Accounting